ID   YKT6_RAT                Reviewed;         198 AA.
AC   Q5EGY4; O35487;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   29-MAY-2024, entry version 120.
DE   RecName: Full=Synaptobrevin homolog YKT6;
DE            EC=2.3.1.-;
DE   Flags: Precursor;
GN   Name=Ykt6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=10073573; DOI=10.1089/104454999315529;
RA   Catchpoole D.R., Wanjin H.;
RT   "Characterization of the sequence and expression of a Ykt6 prenylated SNARE
RT   from rat.";
RL   DNA Cell Biol. 18:141-145(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Peripheral blood;
RA   Lippert U., Ferrari D.M., Jahn R.;
RT   "Expression of rat Ykt6 in rat basophil (RBL) cells.";
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH GOSR1; GOSR2 AND STX5.
RX   PubMed=11323436; DOI=10.1074/jbc.m102786200;
RA   Zhang T., Hong W.;
RT   "Ykt6 forms a SNARE complex with syntaxin 5, GS28, and Bet1 and
RT   participates in a late stage in endoplasmic reticulum-Golgi transport.";
RL   J. Biol. Chem. 276:27480-27487(2001).
RN   [4]
RP   INTERACTION WITH BET1L; GOSR1 AND STX5.
RX   PubMed=11927603; DOI=10.1083/jcb.200112127;
RA   Shorter J., Beard M.B., Seemann J., Dirac-Svejstrup A.B., Warren G.;
RT   "Sequential tethering of Golgins and catalysis of SNAREpin assembly by the
RT   vesicle-tethering protein p115.";
RL   J. Cell Biol. 157:45-62(2002).
RN   [5]
RP   INTERACTION WITH BET1L; GOSR1 AND STX5.
RX   PubMed=12388752; DOI=10.1091/mbc.e02-01-0004;
RA   Xu Y., Martin S., James D.E., Hong W.;
RT   "GS15 forms a SNARE complex with syntaxin 5, GS28, and Ykt6 and is
RT   implicated in traffic in the early cisternae of the Golgi apparatus.";
RL   Mol. Biol. Cell 13:3493-3507(2002).
RN   [6]
RP   TISSUE SPECIFICITY, ISOPRENYLATION, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF CYS-194 AND CYS-195.
RX   PubMed=12589064; DOI=10.1091/mbc.e02-09-0556;
RA   Hasegawa H., Zinsser S., Rhee Y., Vik-Mo E.O., Davanger S., Hay J.C.;
RT   "Mammalian ykt6 is a neuronal SNARE targeted to a specialized compartment
RT   by its profilin-like amino terminal domain.";
RL   Mol. Biol. Cell 14:698-720(2003).
RN   [7]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF VAL-8; PHE-39; PHE-42; ARG-50;
RP   ARG-56 AND VAL-59.
RX   PubMed=15331663; DOI=10.1242/jcs.01314;
RA   Hasegawa H., Yang Z., Oltedal L., Davanger S., Hay J.C.;
RT   "Intramolecular protein-protein and protein-lipid interactions control the
RT   conformation and subcellular targeting of neuronal Ykt6.";
RL   J. Cell Sci. 117:4495-4508(2004).
RN   [8]
RP   PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION) BY C.BOTULINUM NEUROTOXIN TYPE
RP   X.
RX   PubMed=28770820; DOI=10.1038/ncomms14130;
RA   Zhang S., Masuyer G., Zhang J., Shen Y., Lundin D., Henriksson L.,
RA   Miyashita S.I., Martinez-Carranza M., Dong M., Stenmark P.;
RT   "Identification and characterization of a novel botulinum neurotoxin.";
RL   Nat. Commun. 8:14130-14130(2017).
CC   -!- FUNCTION: Vesicular soluble NSF attachment protein receptor (v-SNARE)
CC       mediating vesicle docking and fusion to a specific acceptor cellular
CC       compartment. Functions in endoplasmic reticulum to Golgi transport; as
CC       part of a SNARE complex composed of GOSR1, GOSR2 and STX5. Functions in
CC       early/recycling endosome to TGN transport; as part of a SNARE complex
CC       composed of BET1L, GOSR1 and STX5. Has a S-palmitoyl transferase
CC       activity. {ECO:0000269|PubMed:11323436}.
CC   -!- SUBUNIT: Identified in 2 different SNARE complexes; the first one
CC       composed of GOSR1, GOSR2 and STX5 and the second one composed of BET1L,
CC       GOSR1 and STX5. {ECO:0000269|PubMed:11323436,
CC       ECO:0000269|PubMed:11927603, ECO:0000269|PubMed:12388752}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasmic vesicle membrane;
CC       Lipid-anchor; Cytoplasmic side. Golgi apparatus membrane; Lipid-anchor;
CC       Cytoplasmic side. Note=Probably cycles through vesicles between Golgi
CC       and endosomes. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed by neurons in brain and faintly
CC       detected in spleen, lung and kidney (at protein level). Ubiquitously
CC       expressed. {ECO:0000269|PubMed:12589064}.
CC   -!- DOMAIN: The longin domain regulates palmitoylation and membrane
CC       targeting. {ECO:0000250}.
CC   -!- PTM: Palmitoylated; catalyzes its own palmitoylation. Palmitoylation is
CC       required for Golgi targeting. {ECO:0000250|UniProtKB:O15498}.
CC   -!- PTM: Farnesylation is required for Golgi targeting.
CC       {ECO:0000250|UniProtKB:O15498}.
CC   -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.botulinum
CC       neurotoxin type X (BoNT/X) which hydrolyzes the 173-Lys-|-Ser-174 bond
CC       and probably inhibits neurotransmitter release (PubMed:28770820). It
CC       remains unknown whether BoNT/X is ever produced, or what organisms it
CC       targets. {ECO:0000269|PubMed:28770820}.
CC   -!- SIMILARITY: Belongs to the synaptobrevin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF033027; AAD09152.1; -; mRNA.
DR   EMBL; AY881621; AAW81771.1; -; mRNA.
DR   RefSeq; NP_113880.2; NM_031692.2.
DR   PDB; 3KYQ; X-ray; 2.44 A; A=1-198.
DR   PDBsum; 3KYQ; -.
DR   AlphaFoldDB; Q5EGY4; -.
DR   SMR; Q5EGY4; -.
DR   CORUM; Q5EGY4; -.
DR   IntAct; Q5EGY4; 6.
DR   STRING; 10116.ENSRNOP00000020693; -.
DR   PhosphoSitePlus; Q5EGY4; -.
DR   jPOST; Q5EGY4; -.
DR   PaxDb; 10116-ENSRNOP00000020693; -.
DR   Ensembl; ENSRNOT00000020693.4; ENSRNOP00000020693.1; ENSRNOG00000014785.4.
DR   Ensembl; ENSRNOT00055051755; ENSRNOP00055042693; ENSRNOG00055029861.
DR   Ensembl; ENSRNOT00060055306; ENSRNOP00060045750; ENSRNOG00060031898.
DR   Ensembl; ENSRNOT00065034492; ENSRNOP00065027639; ENSRNOG00065020406.
DR   GeneID; 64351; -.
DR   KEGG; rno:64351; -.
DR   UCSC; RGD:70897; rat.
DR   AGR; RGD:70897; -.
DR   CTD; 10652; -.
DR   RGD; 70897; Ykt6.
DR   eggNOG; KOG0861; Eukaryota.
DR   GeneTree; ENSGT00390000015164; -.
DR   HOGENOM; CLU_074848_3_0_1; -.
DR   InParanoid; Q5EGY4; -.
DR   OMA; HYIGIIR; -.
DR   OrthoDB; 24529at2759; -.
DR   PhylomeDB; Q5EGY4; -.
DR   TreeFam; TF105606; -.
DR   Reactome; R-RNO-204005; COPII-mediated vesicle transport.
DR   Reactome; R-RNO-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-RNO-6811438; Intra-Golgi traffic.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9013408; RHOG GTPase cycle.
DR   EvolutionaryTrace; Q5EGY4; -.
DR   PRO; PR:Q5EGY4; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000014785; Expressed in stomach and 20 other cell types or tissues.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0097441; C:basal dendrite; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:HGNC-UCL.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:HGNC-UCL.
DR   GO; GO:0031201; C:SNARE complex; IDA:HGNC-UCL.
DR   GO; GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; ISS:HGNC-UCL.
DR   GO; GO:0005484; F:SNAP receptor activity; ISO:RGD.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; ISS:HGNC-UCL.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; ISO:RGD.
DR   GO; GO:0006904; P:vesicle docking involved in exocytosis; ISS:HGNC-UCL.
DR   GO; GO:0006903; P:vesicle targeting; ISS:HGNC-UCL.
DR   CDD; cd14824; Longin; 1.
DR   CDD; cd15867; R-SNARE_YKT6; 1.
DR   Gene3D; 1.20.5.110; -; 1.
DR   Gene3D; 3.30.450.50; Longin domain; 1.
DR   InterPro; IPR011012; Longin-like_dom_sf.
DR   InterPro; IPR010908; Longin_dom.
DR   InterPro; IPR045848; R-SNARE_YKT6.
DR   InterPro; IPR042855; V_SNARE_CC.
DR   PANTHER; PTHR45806; SYNAPTOBREVIN HOMOLOG YKT6; 1.
DR   PANTHER; PTHR45806:SF1; SYNAPTOBREVIN HOMOLOG YKT6; 1.
DR   Pfam; PF13774; Longin; 1.
DR   Pfam; PF00957; Synaptobrevin; 1.
DR   SMART; SM01270; Longin; 1.
DR   SUPFAM; SSF58038; SNARE fusion complex; 1.
DR   SUPFAM; SSF64356; SNARE-like; 1.
DR   PROSITE; PS50859; LONGIN; 1.
DR   PROSITE; PS50892; V_SNARE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   ER-Golgi transport; Golgi apparatus; Lipoprotein; Membrane; Methylation;
KW   Palmitate; Phosphoprotein; Prenylation; Protein transport;
KW   Reference proteome; Transferase; Transport.
FT   CHAIN           1..195
FT                   /note="Synaptobrevin homolog YKT6"
FT                   /id="PRO_0000280711"
FT   PROPEP          196..198
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000396663"
FT   DOMAIN          8..131
FT                   /note="Longin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00231"
FT   DOMAIN          138..198
FT                   /note="v-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00290"
FT   SITE            173..174
FT                   /note="(Microbial infection) Cleavage; by C.botulinum
FT                   neurotoxin type X (BoNT/X)"
FT                   /evidence="ECO:0000269|PubMed:28770820"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15498"
FT   MOD_RES         195
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000250"
FT   LIPID           194
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           195
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         8
FT                   /note="V->D: Mistargeted to Golgi and plasma membrane.
FT                   Normally targeted to vesicular structures; when associated
FT                   with A-194 or A-195."
FT                   /evidence="ECO:0000269|PubMed:15331663"
FT   MUTAGEN         39
FT                   /note="F->E: Mistargeted to Golgi and plasma membrane; when
FT                   associated with E-42. Normally targeted to vesicular
FT                   structures; when associated with E-42 and A-195."
FT                   /evidence="ECO:0000269|PubMed:15331663"
FT   MUTAGEN         42
FT                   /note="F->E: Mistargeted to Golgi and plasma membrane; when
FT                   associated with E-39. Normally targeted to vesicular
FT                   structures; when associated with E-39 and A-195."
FT                   /evidence="ECO:0000269|PubMed:15331663"
FT   MUTAGEN         50
FT                   /note="R->E: Mistargeted to Golgi and plasma membrane; when
FT                   associated with E-56. Normally targeted to vesicular
FT                   structures; when associated with E-56 and A-195."
FT                   /evidence="ECO:0000269|PubMed:15331663"
FT   MUTAGEN         56
FT                   /note="R->E: Mistargeted to Golgi and plasma membrane; when
FT                   associated with E-50. Normally targeted to vesicular
FT                   structures; when associated with E-50 and A-195."
FT                   /evidence="ECO:0000269|PubMed:15331663"
FT   MUTAGEN         59
FT                   /note="V->E: Mistargeted to Golgi and plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:15331663"
FT   MUTAGEN         194
FT                   /note="C->A: Loss of prenylation and normally targeted to
FT                   vesicular structures; when associated with A-195. Normally
FT                   targeted to vesicular structures; when associated with D-
FT                   8."
FT                   /evidence="ECO:0000269|PubMed:12589064"
FT   MUTAGEN         195
FT                   /note="C->A: Loss of prenylation and normally targeted to
FT                   vesicular structures; when associated with A-194. Normally
FT                   targeted to vesicular structures; when associated with D-8.
FT                   Normally targeted to vesicular structures; when associated
FT                   with E-39 and E-42. Normally targeted to vesicular
FT                   structures; when associated with E-50 and E-56."
FT                   /evidence="ECO:0000269|PubMed:12589064"
FT   CONFLICT        9
FT                   /note="F -> L (in Ref. 1; AAD09152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        14
FT                   /note="P -> K (in Ref. 1; AAD09152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        100
FT                   /note="E -> Q (in Ref. 1; AAD09152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        107
FT                   /note="R -> T (in Ref. 1; AAD09152)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..11
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   STRAND          16..23
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   TURN            30..32
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           33..49
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   STRAND          55..60
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   STRAND          62..70
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   STRAND          74..82
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           87..104
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           107..109
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   TURN            115..117
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           123..129
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           140..147
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   STRAND          152..156
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           157..159
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           167..173
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:3KYQ"
FT   HELIX           179..191
FT                   /evidence="ECO:0007829|PDB:3KYQ"
SQ   SEQUENCE   198 AA;  22369 MW;  384F4EDBC8295407 CRC64;
     MKLYSLSVFY KGEPKAVLLK AAYDVSSFSF FQRSSVQEFM TFTSQLIVER SAKGSRASVK
     EQEYLCHVYV RSDSLAGVVI ADSEYPSRVA FTLLEKVLDE FSKQVDRIDW PVGSPATIHY
     TALDGHLSRY QNPREADPMS KVQAELDETK IILHNTMESL LERGEKLDDL VSKSEVLGTQ
     SKAFYKTARK QNSCCAIM
//
